Fresh financial and institutional support for the Research in Society programme Blog Post

Once again the ‘Research in Society’ programme run by the Barcelona Science Park (Parc Científic de Barcelona, PCB) will have the financial backing of the Spanish Foundation for Science and Technology (Fundación Española para la Ciencia y Tecnología) and Barcelona City Council in the shape of grants coming to €23,000 and €16,700 respectively. This funding from the two institutions will help secure the development of the PCB’s science popularisation activities and also recognises its firm commitment to driving measures that add to the social dimension of science.   

 

Esteve y Farmamundi renew their collaboration agreement to provide humanitarian aid Blog Post

Esteve and Farmamundi have renewed their collaboration agreement once again, under which the laboratory participates as a member of the organization’s emergency fund and, at the same time, as a provider of medicines. The medical and pharmaceutical material donated by esteve in 2016 were distributed to hospitals, clinics, health centers, welcome centers for sick people, refugee camps, orphanages and nursing homes in 23 countries.

 

A study reveals the biological changes in breast cancer between the primary tumour and metastases Blog Post

Researchers at  the Institute for Research in Biomedicine (IRB Barcelona) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and have described that the longer the time from the onset of the tumour to the development of metastasis is, the more aggressive this cancer becomes. The work – published in Cancer Research– has also shown that between the initial tumour and the metastasis the subtype of breast cancer can change in up to 40% of cases.

 

The Barcelona Science Park launches the 13th edition of BATX2LAB Blog Post

El Barcelona Science Park (PCB) is organizing for the third year in a row a new edition of BATX2LAB, a tutoring program for research projects undertaken by secondary school students. An informative session will be held on 26 April at 16.00 hours at the PCB´s Auditorium aimed at the teaching stuff of students interested in participating in the program. At this session, teachers will be informed of how the program works and the specific research areas of the scientists who will serve as tutors in this year´s edition.

 

Awards of the UB Board of Trustees and the FBG: Ten years fostering knowledge transfer Blog Post

The Awards of the Board of Trustees of the University of Barcelona (UB) and Bosch i Gimpera Foundation (FBG) –based at the Barcelona Science Park (PCB)– celebrate their tenth edition. These prizes are awarded in two categories: the Antoni Caparrós Prize for the best knowledge transfer project, and the Senén Vilaró Prize for the best innovative company which, since its creation in 2008, has recognized eight companies based at PCB: Meteosim, Biocontrol Technologies, Intelligent Pharma, Enantia, Neurotec Pharma, Infinitec Assets, Endor Technologies and Minoryx Therapeutics.

 

Bionure project of the GAEM’s Accelerator Programme raises more than €1M via equity crowdfunding Blog Post

With more than €1M raised, Bionure’s campaign ‘#estamosaesto‘ (‘we are this close’) is currently overfunding on the Capital Cell crowdfunding platform.These funds will be used by the company to develop BN201, a promising first-in-class drug candidate halt the development of Multiple Sclerosis (MS). Bionure’s MS drug candidate is one of the projects promotes by the Accelerator Programme of GAEM Foundation from its headquarters at the Barcelona Science Park (PCB).

 

Minoryx successfully completes phase 1 clinical trial for lead candidate MIN-102 Blog Post

Minoryx Therapeutics – a drug development company specialized in the discovery and development of new drugs for orphan diseases, which has R& D laboratories at the Barcelona Science Park– announces that it has successfully completed its phase 1 trial with its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease with high unmet medical need.

 

Samuel receives the Catalonian National Research Award for Young Talent Blog Post

Yesterday IBEC group leader and ICREA research professor Samuel Sánchez at PCB, received the Catalonian National Research Award for Young Talent from the Catalan Government and the Catalan Foundation for Research and Innovation (FCRI).This prestigious honour and cash prize of €10,000 aims to encourage and acknowledge young researchers whose work and research has stood out during their professional career.

 

The AECC supports cancer research at IRB Barcelona Blog Post

Today, Jelena Urosevic and Carles Barceló, postdoctoral fellows at the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park, will officially be presented with funding over 5 years from the Asociación Española Contra el Cáncer (AECC) for their respective research projects on colon cancer. To date, IRB Barcelona has secured AECC funding for eight cancer projects.